Published in Proc Natl Acad Sci U S A on March 08, 2010
Comprehensive Study of Post-surgical Pain After Pectus or Spine Surgery | NCT04031716
Phenomics and Genomics of Clinically Relevant Chronic Postsurgical Pain (CT-Pain) | NCT04798573
The Na(V)1.7 sodium channel: from molecule to man. Nat Rev Neurosci (2012) 2.71
Pain sensitivity and opioid analgesia: a pharmacogenomic twin study. Pain (2012) 2.44
Multiple chronic pain states are associated with a common amino acid-changing allele in KCNS1. Brain (2010) 2.41
Nociceptor sensitization in pain pathogenesis. Nat Med (2010) 2.13
Genetic epidemiology of hip and knee osteoarthritis. Nat Rev Rheumatol (2010) 1.67
Mechanisms and management of diabetic painful distal symmetrical polyneuropathy. Diabetes Care (2013) 1.62
Overcoming obstacles to developing new analgesics. Nat Med (2010) 1.54
Heat avoidance is regulated by transient receptor potential (TRP) channels and a neuropeptide signaling pathway in Caenorhabditis elegans. Genetics (2011) 1.37
Pain as a channelopathy. J Clin Invest (2010) 1.33
Recent developments regarding voltage-gated sodium channel blockers for the treatment of inherited and acquired neuropathic pain syndromes. Front Pharmacol (2011) 1.16
Genetic basis of pain variability: recent advances. J Med Genet (2011) 1.14
Discovery of a selective NaV1.7 inhibitor from centipede venom with analgesic efficacy exceeding morphine in rodent pain models. Proc Natl Acad Sci U S A (2013) 1.11
Intra- and interfamily phenotypic diversity in pain syndromes associated with a gain-of-function variant of NaV1.7. Mol Pain (2011) 1.09
Genetic variants associated with development of TMD and its intermediate phenotypes: the genetic architecture of TMD in the OPPERA prospective cohort study. J Pain (2013) 1.08
Abnormal endogenous pain modulation is a shared characteristic of many chronic pain conditions. Expert Rev Neurother (2012) 1.05
Towards a mechanism-based approach to pain management in osteoarthritis. Nat Rev Rheumatol (2013) 1.04
A SCN9A gene-encoded dorsal root ganglia sodium channel polymorphism associated with severe fibromyalgia. BMC Musculoskelet Disord (2012) 1.02
Global Nav1.7 knockout mice recapitulate the phenotype of human congenital indifference to pain. PLoS One (2014) 1.02
Dysregulation of voltage-gated sodium channels by ubiquitin ligase NEDD4-2 in neuropathic pain. J Clin Invest (2013) 0.99
Modeling pain in vitro using nociceptor neurons reprogrammed from fibroblasts. Nat Neurosci (2014) 0.96
Pharmacogenetics of new analgesics. Br J Pharmacol (2011) 0.95
A role for PACE4 in osteoarthritis pain: evidence from human genetic association and null mutant phenotype. Ann Rheum Dis (2012) 0.94
Epigenetics and the transition from acute to chronic pain. Pain Med (2012) 0.93
Nature and nurture of human pain. Scientifica (Cairo) (2013) 0.89
Infrequent SCN9A mutations in congenital insensitivity to pain and erythromelalgia. J Neurol Neurosurg Psychiatry (2012) 0.89
Seven novel modulators of the analgesic target NaV 1.7 uncovered using a high-throughput venom-based discovery approach. Br J Pharmacol (2015) 0.87
Biological pathways, candidate genes, and molecular markers associated with quality-of-life domains: an update. Qual Life Res (2014) 0.86
In vivo regulation of NGF-mediated functions by Nedd4-2 ubiquitination of TrkA. J Neurosci (2014) 0.85
Genetic variability of pain perception and treatment--clinical pharmacological implications. Eur J Clin Pharmacol (2011) 0.84
Ion channelopathies in functional GI disorders. Am J Physiol Gastrointest Liver Physiol (2016) 0.84
Neuropathic pain as part of chronic widespread pain: environmental and genetic influences. Pain (2015) 0.84
Pharmacogenetics of analgesic drugs. Br J Pain (2013) 0.83
Understanding of molecular pain medicine: genetic basis of variation in pain sensation and analgesia response. Anesth Pain Med (2013) 0.83
Osteoarthritis-dependent changes in antinociceptive action of Nav1.7 and Nav1.8 sodium channel blockers: An in vivo electrophysiological study in the rat. Neuroscience (2015) 0.82
Extending the clinical spectrum of pain channelopathies. Brain (2012) 0.82
Contribution of the COMT Val158Met variant to symptomatic knee osteoarthritis. Ann Rheum Dis (2013) 0.81
The role of sodium channels in chronic pain. Muscle Nerve (2012) 0.81
Linkage between increased nociception and olfaction via a SCN9A haplotype. PLoS One (2013) 0.80
A practical guide and perspectives on the use of experimental pain modalities with children and adolescents. Pain Manag (2014) 0.80
Epigenetic regulation of persistent pain. Transl Res (2014) 0.80
Antinociceptive effects of lacosamide on spinal neuronal and behavioural measures of pain in a rat model of osteoarthritis. Arthritis Res Ther (2014) 0.80
The non-synonymous SNP, R1150W, in SCN9A is not associated with chronic widespread pain susceptibility. Mol Pain (2012) 0.80
Optical electrophysiology for probing function and pharmacology of voltage-gated ion channels. Elife (2016) 0.79
Evaluation of behavior and expression of NaV1.7 in dorsal root ganglia after sciatic nerve compression and application of nucleus pulposus in rats. Eur Spine J (2013) 0.78
SCN9A Variants May be Implicated in Neuropathic Pain Associated With Diabetic Peripheral Neuropathy and Pain Severity. Clin J Pain (2015) 0.78
Toward a Mechanism-Based Approach to Pain Diagnosis. J Pain (2016) 0.78
Targeting voltage-gated sodium channels for treatment for chronic visceral pain. World J Gastroenterol (2011) 0.77
Correlation of the electrophysiological profiles and sodium channel transcripts of individual rat dorsal root ganglia neurons. Front Cell Neurosci (2014) 0.77
Emerging Targets for the Management of Osteoarthritis Pain. Curr Osteoporos Rep (2016) 0.77
Translating the human genome to manage pediatric postoperative pain. J Pediatr Surg Nurs (2015) 0.76
Transforming pain medicine: adapting to science and society. Eur J Pain (2013) 0.76
At the borders of medical reasoning: aetiological and ontological challenges of medically unexplained symptoms. Philos Ethics Humanit Med (2013) 0.76
A Conceptual Model of Psychoneurological Symptom Cluster Variation in Women with Breast Cancer: Bringing Nursing Research to Personalized Medicine. Curr Pharmacogenomics Person Med (2013) 0.75
Genes, molecules and patients--emerging topics to guide clinical pain research. Eur J Pharmacol (2013) 0.75
Opioidergic tone and pain susceptibility: interactions between reward systems and opioid receptors. Pain (2017) 0.75
Evaluating the clinical relevance of codon 594 (g>a) polymorphism of estrogen receptor alpha in knee osteoarthritis. Malays Orthop J (2014) 0.75
Managing Chronic Pain in Special Populations with Emphasis on Pediatric, Geriatric, and Drug Abuser Populations. Med Clin North Am (2016) 0.75
Genes associated with persistent lumbar radicular pain; a systematic review. BMC Musculoskelet Disord (2016) 0.75
Genetic polymorphisms of SCN9A are associated with oxaliplatin-induced neuropathy. BMC Cancer (2017) 0.75
Low back pain in older adults: risk factors, management options and future directions. Scoliosis Spinal Disord (2017) 0.75
The design and methods of genetic studies on acute and chronic postoperative pain in patients after total knee replacement. Pain Med (2014) 0.75
Efficacy of Anti-NaV1.7 Antibody on the Sensory Nervous System in a Rat Model of Lumbar Intervertebral Disc Injury. Yonsei Med J (2016) 0.75
Genomics of pain in osteoarthritis. Osteoarthritis Cartilage (2013) 0.75
A SCN10A SNP biases human pain sensitivity. Mol Pain (2016) 0.75
Association of rare missense variants in the second intracellular loop of NaV1.7 sodium channels with familial autism. Mol Psychiatry (2016) 0.75
SCN11A variants may influence postoperative pain sensitivity after gynecological surgery in Chinese Han female patients. Medicine (Baltimore) (2017) 0.75
Combining probability from independent tests: the weighted Z-method is superior to Fisher's approach. J Evol Biol (2005) 7.46
An SCN9A channelopathy causes congenital inability to experience pain. Nature (2006) 7.01
Lost productive time and cost due to common pain conditions in the US workforce. JAMA (2003) 6.60
Genetic basis for individual variations in pain perception and the development of a chronic pain condition. Hum Mol Genet (2004) 5.87
SCN9A mutations in paroxysmal extreme pain disorder: allelic variants underlie distinct channel defects and phenotypes. Neuron (2006) 3.96
Mutations in SCN9A, encoding a sodium channel alpha subunit, in patients with primary erythermalgia. J Med Genet (2004) 3.45
GTP cyclohydrolase and tetrahydrobiopterin regulate pain sensitivity and persistence. Nat Med (2006) 3.38
The Maine Lumbar Spine Study, Part II. 1-year outcomes of surgical and nonsurgical management of sciatica. Spine (Phila Pa 1976) (1996) 2.91
Catechol-O-methyltransferase gene polymorphisms are associated with multiple pain-evoking stimuli. Pain (2006) 2.75
A single sodium channel mutation produces hyper- or hypoexcitability in different types of neurons. Proc Natl Acad Sci U S A (2006) 2.61
Mutations in sodium-channel gene SCN9A cause a spectrum of human genetic pain disorders. J Clin Invest (2007) 2.58
Can we conquer pain? Nat Neurosci (2002) 2.56
Slow closed-state inactivation: a novel mechanism underlying ramp currents in cells expressing the hNE/PN1 sodium channel. J Neurosci (1998) 2.30
Loss-of-function mutations in the Nav1.7 gene underlie congenital indifference to pain in multiple human populations. Clin Genet (2007) 2.15
The roles of sodium channels in nociception: Implications for mechanisms of pain. Pain (2007) 2.06
Chronic pain and poor self-rated health. JAMA (2003) 1.95
NaV1.7 gain-of-function mutations as a continuum: A1632E displays physiological changes associated with erythromelalgia and paroxysmal extreme pain disorder mutations and produces symptoms of both disorders. J Neurosci (2008) 1.70
Expression of alternatively spliced sodium channel alpha-subunit genes. Unique splicing patterns are observed in dorsal root ganglia. J Biol Chem (2004) 1.67
Capsaicin receptor: TRPV1 a promiscuous TRP channel. Handb Exp Pharmacol (2007) 1.56
Genetic architecture of human pain perception. Trends Genet (2007) 1.48
SCN9A mutations define primary erythermalgia as a neuropathic disorder of voltage gated sodium channels. J Invest Dermatol (2005) 1.41
Erythermalgia: molecular basis for an inherited pain syndrome. Trends Mol Med (2005) 1.39
A Nav1.7 channel mutation associated with hereditary erythromelalgia contributes to neuronal hyperexcitability and displays reduced lidocaine sensitivity. J Physiol (2007) 1.35
A sodium channel gene SCN9A polymorphism that increases nociceptor excitability. Ann Neurol (2009) 1.25
Pharmacological management of pain in chronic pancreatitis. Dig Liver Dis (2006) 1.13
Evolutionary and comparative aspects of nociception. Brain Res Bull (1988) 1.11
Phenotypic and population differences in the association between CILP and lumbar disc disease. J Med Genet (2007) 1.07
Tramadol for osteoarthritis: a systematic review and metaanalysis. J Rheumatol (2007) 1.02
Mexiletine-responsive erythromelalgia due to a new Na(v)1.7 mutation showing use-dependent current fall-off. Exp Neurol (2008) 1.02
Beware of a half-tailed test. Psychol Bull (1986) 0.89
Fish, amphibian, and reptile analgesia. Vet Clin North Am Exot Anim Pract (2001) 0.84
In vivo investigation of genome activity and synaptic plasticity of neurons in snails during learning. Neurosci Behav Physiol (2005) 0.79
Pain perception and alleviation in animals. Fed Proc (1984) 0.79
Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences. Proc Natl Acad Sci U S A (2002) 20.48
Recurrent rearrangements of chromosome 1q21.1 and variable pediatric phenotypes. N Engl J Med (2008) 10.88
An SCN9A channelopathy causes congenital inability to experience pain. Nature (2006) 7.01
Flies without centrioles. Cell (2006) 6.06
A splicing mutation affecting expression of ataxia-telangiectasia and Rad3-related protein (ATR) results in Seckel syndrome. Nat Genet (2003) 6.03
Genetic basis for individual variations in pain perception and the development of a chronic pain condition. Hum Mol Genet (2004) 5.87
Glucose sensing in L cells: a primary cell study. Cell Metab (2008) 5.53
A centrosomal mechanism involving CDK5RAP2 and CENPJ controls brain size. Nat Genet (2005) 5.48
Mutations in genes encoding ribonuclease H2 subunits cause Aicardi-Goutières syndrome and mimic congenital viral brain infection. Nat Genet (2006) 5.26
ASPM is a major determinant of cerebral cortical size. Nat Genet (2002) 4.57
Diagnostic Criteria for Temporomandibular Disorders (DC/TMD) for Clinical and Research Applications: recommendations of the International RDC/TMD Consortium Network* and Orofacial Pain Special Interest Group†. J Oral Facial Pain Headache (2014) 4.25
Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase. Nat Genet (2006) 4.01
Proteome-wide analysis and CXCL4 as a biomarker in systemic sclerosis. N Engl J Med (2013) 3.81
Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations. Arch Neurol (2003) 3.80
Primary microcephaly: do all roads lead to Rome? Trends Genet (2009) 3.60
Gain of function Naν1.7 mutations in idiopathic small fiber neuropathy. Ann Neurol (2011) 3.53
GTP cyclohydrolase and tetrahydrobiopterin regulate pain sensitivity and persistence. Nat Med (2006) 3.38
Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from L cells and alpha cells. Nat Med (2011) 3.31
A gain-of-function mutation in TRPA1 causes familial episodic pain syndrome. Neuron (2010) 3.31
The transmembrane protein meckelin (MKS3) is mutated in Meckel-Gruber syndrome and the wpk rat. Nat Genet (2006) 3.19
Identification of microcephalin, a protein implicated in determining the size of the human brain. Am J Hum Genet (2002) 3.13
Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-protein-coupled receptor FFAR2. Diabetes (2011) 3.06
PLA2G6, encoding a phospholipase A2, is mutated in neurodegenerative disorders with high brain iron. Nat Genet (2006) 2.97
Selection of genetic markers for association analyses, using linkage disequilibrium and haplotypes. Am J Hum Genet (2003) 2.94
Insulin storage and glucose homeostasis in mice null for the granule zinc transporter ZnT8 and studies of the type 2 diabetes-associated variants. Diabetes (2009) 2.92
Hyperphagia, severe obesity, impaired cognitive function, and hyperactivity associated with functional loss of one copy of the brain-derived neurotrophic factor (BDNF) gene. Diabetes (2006) 2.87
Catechol-O-methyltransferase gene polymorphisms are associated with multiple pain-evoking stimuli. Pain (2006) 2.75
Idiopathic pain disorders--pathways of vulnerability. Pain (2006) 2.69
Na(+)-D-glucose cotransporter SGLT1 is pivotal for intestinal glucose absorption and glucose-dependent incretin secretion. Diabetes (2011) 2.65
Mutations in the cilia gene ARL13B lead to the classical form of Joubert syndrome. Am J Hum Genet (2008) 2.65
Genetically mediated interindividual variation in analgesic responses to cyclooxygenase inhibitory drugs. Clin Pharmacol Ther (2006) 2.59
Overlap of endocrine hormone expression in the mouse intestine revealed by transcriptional profiling and flow cytometry. Endocrinology (2012) 2.56
Prevalence and pattern of lumbar magnetic resonance imaging changes in a population study of one thousand forty-three individuals. Spine (Phila Pa 1976) (2009) 2.56
Perceived intensity and unpleasantness of cutaneous and auditory stimuli: an evaluation of the generalized hypervigilance hypothesis. Pain (2009) 2.55
Genetic cause of hyperglycaemia and response to treatment in diabetes. Lancet (2003) 2.54
Development and initial validation of an expanded and revised version of the Short-form McGill Pain Questionnaire (SF-MPQ-2). Pain (2009) 2.53
Nucleotide-binding oligomerization domain-2 modulates specific TLR pathways for the induction of cytokine release. J Immunol (2005) 2.52
Chymotrypsin C (CTRC) variants that diminish activity or secretion are associated with chronic pancreatitis. Nat Genet (2007) 2.48
Identifying important outcome domains for chronic pain clinical trials: an IMMPACT survey of people with pain. Pain (2007) 2.47
Comparison of peri- and intraarticular analgesia with femoral nerve block after total knee arthroplasty: a randomized clinical trial. Acta Orthop (2007) 2.45
Multiple chronic pain states are associated with a common amino acid-changing allele in KCNS1. Brain (2010) 2.41
WDR62 is associated with the spindle pole and is mutated in human microcephaly. Nat Genet (2010) 2.40
A genome-wide Drosophila screen for heat nociception identifies α2δ3 as an evolutionarily conserved pain gene. Cell (2010) 2.37
Lanreotide reduces the volume of polycystic liver: a randomized, double-blind, placebo-controlled trial. Gastroenterology (2009) 2.33
Loss-of-function mutations in sodium channel Nav1.7 cause anosmia. Nature (2011) 2.31
Characterization of hepatitis C virus intergenotypic recombinant strains and associated virological response to sofosbuvir/ribavirin. Hepatology (2014) 2.27
Phantom limb pain: a case of maladaptive CNS plasticity? Nat Rev Neurosci (2006) 2.26
INPP5E mutations cause primary cilium signaling defects, ciliary instability and ciliopathies in human and mouse. Nat Genet (2009) 2.26
Vertebral endplate signal changes (Modic change): a systematic literature review of prevalence and association with non-specific low back pain. Eur Spine J (2008) 2.25
Genetically determined P2X7 receptor pore formation regulates variability in chronic pain sensitivity. Nat Med (2012) 2.25
The association between obesity and low back pain: a meta-analysis. Am J Epidemiol (2009) 2.24
Developing patient-reported outcome measures for pain clinical trials: IMMPACT recommendations. Pain (2006) 2.23
Pain in multiple sites and sickness absence trajectories: a prospective study among Finns. Pain (2012) 2.23
Glucose-sensing in glucagon-like peptide-1-secreting cells. Diabetes (2002) 2.21
TCF7L2 polymorphisms modulate proinsulin levels and beta-cell function in a British Europid population. Diabetes (2007) 2.20
Gene expression analysis of purified hematopoietic stem cells and committed progenitors. Blood (2003) 2.05
A randomized, placebo-controlled trial of oxycodone and of gabapentin for acute pain in herpes zoster. Pain (2009) 2.01
Association of functional variations in COMT and GCH1 genes with postherniotomy pain and related impairment. Pain (2015) 2.01
Use of the cumulative proportion of responders analysis graph to present pain data over a range of cut-off points: making clinical trial data more understandable. J Pain Symptom Manage (2006) 1.99
Association of catechol-O-methyltransferase genetic variants with outcome in patients undergoing surgical treatment for lumbar degenerative disc disease. Spine J (2010) 1.98
A population-based study of juvenile disc degeneration and its association with overweight and obesity, low back pain, and diminished functional status. J Bone Joint Surg Am (2011) 1.97
Spectrum of MKS1 and MKS3 mutations in Meckel syndrome: a genotype-phenotype correlation. Mutation in brief #960. Online. Hum Mutat (2007) 1.93
Mucolipin-1 is a lysosomal membrane protein required for intracellular lactosylceramide traffic. Traffic (2006) 1.92
Identification and characterization of GLP-1 receptor-expressing cells using a new transgenic mouse model. Diabetes (2013) 1.90
NOD2 mediates anti-inflammatory signals induced by TLR2 ligands: implications for Crohn's disease. Eur J Immunol (2004) 1.90
Protein-truncating mutations in ASPM cause variable reduction in brain size. Am J Hum Genet (2003) 1.89
The association between smoking and low back pain: a meta-analysis. Am J Med (2010) 1.86
Nutritional regulation of glucagon-like peptide-1 secretion. J Physiol (2008) 1.86
Effect of two- and three-locus linkage disequilibrium on the power to detect marker/phenotype associations. Genetics (2004) 1.85
Multiple tests for genetic effects in association studies. Methods Mol Biol (2002) 1.85
A meta-analysis identifies new loci associated with body mass index in individuals of African ancestry. Nat Genet (2013) 1.82